Previous studies have shown that metformin reduces Nrf2 level in non-small cell lung cancer cells [49] and hepatocellular carcinoma cells [50] by increasing the ubiquitination and proteasomal degradation of Nrf2. Here, NFE2L2 is linked to non-small cell lung carcinoma.